Two-year delay in ulcerative colitis diagnosis is associated with anti-tumor necrosis factor alpha use

doi:10.3748/wjg.v25.i8.989

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7486)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-6) series.

Item

Count

PDF

452

WORD

327

HTML

3495

Figures (1-2)

285

Tables (1-6)

255

Sum=4814

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1314

Download

1358

Sum=2672

Feb 28, 2019 (publication date) through Nov 29, 2024

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Feb 28, 2019; 25(8): 989-1001
Published online Feb 28, 2019. doi: 10.3748/wjg.v25.i8.989

Full Size Figure Download Figure

Figure 1 Difference in the anti-tumor necrosis factor alpha use rate (%) according to the diagnostic interval. Anti-TNFα: Anti-tumor necrosis factor alpha.

Citation: Kang HS, Koo JS, Lee KM, Kim DB, Lee JM, Kim YJ, Yoon H, Jang HJ. Two-year delay in ulcerative colitis diagnosis is associated with anti-tumor necrosis factor alpha use. World J Gastroenterol 2019; 25(8): 989-1001
URL: https://www.wjgnet.com/1007-9327/full/v25/i8/989.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i8.989